Aventis Pharma Ltd has announced the following Unaudited results for the quarter ended September 30, 2006:
The Company has posted a net profit of Rs 538 million for the quarter ended September 30, 2006 as compared to Rs 497 million for the quarter ended September 30, 2005. Total Income (net of excise) has increased from Rs 2315 million for the quarter ended September 30, 2005 to Rs 2587 million for the quarter ended September 30, 2006.
